↑ Orjales, A; Mosquera, R; Labeaga, L; Rodes, R (ngày 14 tháng 2 năm 1997). “New 2-Piperazinylbenzimidazole Derivatives as 5-HT3 Antagonists. Synthesis and Pharmacological Evaluation”. Journal of Medicinal Chemistry. 40 (4): 586–93. doi:10.1021/jm960442e. PMID9046349.
↑ Gomez-de-Segura, IA; Grande, AG; De Miguel, E (1998). “Antiemetic Effects of Lerisetron in Radiation-Induced Emesis in the Dog”. Acta Oncologica. 37 (7–8): 759–63. PMID10050999.
↑ Cooper, M; Sologuren, A; Valiente, R; Smith, J (2002). “Effects of Lerisetron, a New 5-HT3 Receptor Antagonist, on Ipecacuanha-Induced Emesis in Healthy Volunteers”. Arzneimittel-Forschung. 52 (9): 689–94. doi:10.1055/s-0031-1299952. PMID12404884.
↑ Huckle, R (tháng 7 năm 2003). “Lerisetron. FAES”. Current Opinion in Investigational Drugs. 4 (7): 874–7. PMID14619411.
